Skip to main content
. 2011 Jul 25;29(25):3381–3388. doi: 10.1200/JCO.2010.34.3426

Table A2.

Characteristics of Patients Undergoing Resection for Stage II/III Colon Cancer After Propensity Score Weighting

Characteristic Stage II With No Poor Prognostic Features (n = 6,234)
Stage II With Any Poor Prognostic Features (n = 18,613)
Stage III (n = 18,185)
No Chemo (81%) Chemo (19%) P No Chemo (79%) Chemo (21%) P No Chemo (43%) Chemo (57%) P
Patient characteristics
    Age, years, % .93 .98 .99
        65-69 13.0 13.1 10.6 10.7 13.4 13.3
        70-74 20.8 20.5 19.1 19.1 21.8 21.8
        75-79 25.5 25.1 24.1 24.4 25.1 25.2
        80-84 23.1 22.3 23.2 22.9 21.6 21.7
        85+ 17.7 19.0 23.1 22.9 18.1 18.1
    Male sex, % 43.2 47.0 .10 39.6 48.2 < .001 40.8 43.0 .02
    Race/ethnicity, % .08 .07 < .001
        White 86.6 87.7 86.6 87.1 81.3 85.2
        Black 5.8 3.5 6.4 5.0 9.3 5.7
        Asian or Pacific Islander 4.1 5.0 3.4 3.4 5.1 4.9
        Hispanic or other 3.5 3.7 3.7 4.5 4.3 4.2
    SEER registry, % .10 .14 < .001
        California 26.5 31.7 28.7 27.3 27.0 28.1
        Connecticut 8.8 9.9 9.8 10.3 9.1 11.2
        Detroit 2.5 2.6 10.7 11.9 11.8 10.9
        Hawaii 12.6 10.8 1.2 0.8 2.2 1.8
        Iowa 2.7 2.3 14.6 13.5 12.0 12.4
        New Mexico 7.5 6.4 2.3 2.3 3.1 2.6
        Seattle 3.4 3.2 7.4 6.5 7.0 6.5
        Utah 4.1 3.7 2.7 2.4 3.4 3.1
        Atlanta and rural Georgia 5.5 5.0 4.0 3.6 4.3 3.4
        Kentucky 4.3 5.2 4.4 5.2 5.5 4.5
        Louisiana 10.5 11.5 4.3 5.2 4.6 4.2
        New Jersey 26.5 31.7 9.9 11.0 10.1 11.4
    Marital status, % .20 .33 .80
        Married 53.1 56.9 47.4 49.5 50.6 51.6
        Widowed 32.6 30.7 37.5 35.2 34.0 33.4
        Single, separated, or divorced 11.2 8.7 11.9 12.2 12.5 12.1
        Unknown 3.1 3.7 3.1 3.2 2.9 2.9
    Residence location, % .02 .73 .38
        Major metropolitan 53.8 60.1 55.3 55.6 57.1 55.7
        Metropolitan or urban 35.5 30.6 34.0 33.2 32.8 33.6
        Less urban or rural 10.8 9.3 10.7 11.2 10.2 10.7
    Median household income (census tract), $ in thousands .07 .006 < .001
        Mean* 46.8 48.8 44.2 44.1 43.8 45.6
        95% CI 46.1, 47.5 46.4, 51.2 43.8, 44.6 43.0, 45.1 43.1, 44.5 45.0, 46.2
    Less than 12 yr education (census tract), % .97 .61 < .001
        Mean* 18.1 18.2 19.4 19.6 20.0 19.2
        95% CI 17.8, 18.5 17.1, 19.4 19.2, 19.6 19.0, 20.2 19.6, 20.4 18.8, 19.5
    HCC comorbidity score < .001 < .001 < .001
        Mean 1.7 1.8 2.1 2.1 2.6 2.6
        95% CI 1.7, 1.8 1.7, 1.9 2.1, 2.1 2.0, 2.1 2.5, 2.6 2.5, 2.6
Tumor characteristics
    Year of diagnosis, % .12 .78 .95
        1992-1995 18.0 15.4 22.7 22.1 19.6 19.7
        1996-1999 18.8 17.3 21.7 21.0 19.7 20.1
        2000-2002 29.6 29.1 29.6 30.2 29.6 29.5
        2003-2005 33.6 38.2 26.0 26.7 31.2 30.7
    Tumor location, % .47 .10 .08
        Right colon 63.9 63.4 53.7 52.9 56.3 57.8
        Transverse colon 10.1 8.1 11.7 9.9 10.8 9.3
        Left colon 8.1 9.1 10.2 10.9 9.3 8.8
        Sigmoid colon 16.3 17.9 22.9 24.5 21.9 22.2
        Unknown 1.6 1.5 1.5 1.8 1.7 1.9
Comorbidity and treatment measures
    Any hospitalization in the previous year, % 26.4 28.0 .48 27.4 26.6 .49 26.6 26.4 .79
    Rehospitalization within 30 days of discharge, % 10.8 8.2 .04 12.1 12.1 .94 11.8 12.2 .47
    Any in-hospital surgical complication, % 2.8 2.9 .92 4.1 4.4 .58 3.7 3.7 .94
    Oncologist visit within 30 days of surgery, % 28.1 27.6 .80 29.7 29.9 .89 45.2 45.5 .82
Poor prognostic features
    Emergent admission, % NA NA 25.7 23.6 .07 24.1 18.8 < .001
    Intestinal obstruction on admission, % NA NA 6.0 6.5 .31 5.5 4.7 .07
    Intestinal perforation on admission, % NA NA 2.4 4.1 < .001 2.3 1.7 .03
    T stage, % < .001 .16
        Tis, T0, T1, or T2 NA NA 0.0 0.0 10.2 11.2
        T3 0.5 0.5 82.8 74.0 70.4 70.4
        T4 NA NA 17.2 26.0 19.4 18.4
    No. of nodes resected, % .01 .32
        0-11 NA NA 72.5 69.7 49.8 48.8
        ≥ 12 0.5 0.5 27.5 30.3 50.3 51.2
    Tumor grade, % .86 .05 .68
        Well differentiated 0.0 0.0 7.5 7.1 5.4 5.1
        Moderately differentiated 0.5 0.5 66.7 64.2 63.9 63.6
        Poorly or undifferentiated NA NA 25.9 28.8 30.8 31.3
    No. of poor prognostic features, % < .001 < .001
        0 0.5 0.5 NA NA 21.5 22.8
        1 NA NA 61.2 56.5 39.9 42.3
        2 NA NA 29.7 30.6 26.7 25.3
        3 NA NA 7.6 10.9 9.6 7.7
        4, 5, or 6 NA NA 1.5 2.0 2.3 1.9

NOTE. Percentages may not sum to 100% because of rounding.

Abbreviations: Chemo, chemotherapy; SEER, Surveillance, Epidemiology, and End Results; SD, standard deviation; HCC, Hierarchical Condition Categories; NA, not applicable.

*

A total of 2,243 individuals with missing data were not included in these means.

Three SEER registries (Kentucky, Louisiana, New Jersey) were added in 2000.

HHS Vulnerability Disclosure